Unless you’ve been living under a rock, you know that weight-loss drugs are the talk of the town. GLP-1 drugs, in particular, ...

Novo Nordisk's CagriSema fell short of weight loss goals, causing 17% stock drop. Drug shows similar results to Eli Lilly's ...

The Broadway icon said he’s a “great believer” in the weight-loss medication, which helped him after he weighed 310 lbs.

Chances are that whenever you take a pill, dab on ointment or have a vaccine, it will have been tested on a humble mouse. But ...

Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...

There can be unpredictable side effects from taking uncertified weight loss jabs because the medicines will not have been ...

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Lilly’s Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating o ...